The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A real-world (rw) evidence study quantifying the clinical value of multi-gene testing in early-stage lung adenocarcinoma (LUAD).
 
Nathan A. Pennell
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cota Healthcare; G1 Therapeutics; Genentech; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer; Sanofi/Regeneron; Viosera Therapeutics; Xencor
Research Funding - Altor BioScience (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Heat Biologics (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); WindMIL (Inst)
 
Liangliang Zhang
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Katherine T Lofgren
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Bharathi Muthusamy
No Relationships to Disclose
 
Emily Castellanos
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health; Roche
 
Karen Schwed
Employment - Flatiron Health; Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Roche/Genentech
 
Olivier Humblet
Employment - Flatiron Health
Stock and Other Ownership Interests - Roche
 
Alexa Betzig Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine; Roche
 
Geoffrey R. Oxnard
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche